Treatment of Metastatic Renal Cell Carcinoma With CAIX CAR-engineered T cells: Clinical Evaluation and Management of On-target Toxicity

C. B. H. W. Lamers(Erasmus MC), Stefan Sleijfer(Erasmus MC), Sabine van Steenbergen(Erasmus MC), Pascal van Elzakker(Erasmus MC), Brigitte van Krimpen(Erasmus MC), C.A.M. van der Velden-de Groot(Erasmus MC), Arnold G. Vulto(Erasmus MC), Michael den Bakker(Erasmus MC), Egbert Oosterwijk(Radboud University Nijmegen), Reno Debets(Erasmus MC), Jan W. Gratama(Erasmus MC)
Molecular Therapy
February 19, 2013
10.1038/mt.2013.17
Cited by 705Open Access
Full Text

Abstract

Related Papers

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. Eisenhauer, P. Therasse, Jan Bogaerts et al.|European Journal of Cancer|2008|29.3k
B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor–transduced T cells
James N. Kochenderfer, Mark E. Dudley, Steven A. Feldman et al.|Blood|2011|1.4k
Adoptive T cell therapy using antigen-specific CD8<sup>+</sup>T cell clones for the treatment of patients with metastatic melanoma:<i>In vivo</i>persistence, migration, and antitumor effect of transferred T cells
Cassian Yee, John A. Thompson, D. Byrd et al.|Proceedings of the National Academy of Sciences|2002|1.2k
T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis
Maria R. Parkhurst, James C. Yang, Russell C. Langan et al.|Molecular Therapy|2010|1k
Cancer/testis (CT) antigens: Potential targets for immunotherapy
Otávia L. Caballero, Yao‐Tseng Chen|Cancer Science|2009|555